US 12139499
Heteroaryl compounds for treating Huntington's disease
granted A61PA61P25/00A61P25/14
Quick answer
US patent 12139499 (Heteroaryl compounds for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/28